D
Demetra Philippidou
Researcher at University of Luxembourg
Publications - 18
Citations - 858
Demetra Philippidou is an academic researcher from University of Luxembourg. The author has contributed to research in topics: Melanoma & microRNA. The author has an hindex of 11, co-authored 15 publications receiving 760 citations.
Papers
More filters
Journal ArticleDOI
Signatures of MicroRNAs and Selected MicroRNA Target Genes in Human Melanoma
Demetra Philippidou,Martina Schmitt,Dirk Moser,Christiane Margue,Petr V. Nazarov,Arnaud Muller,Laurent Vallar,Dorothee Nashan,Iris Behrmann,Stephanie Kreis +9 more
TL;DR: This study identified a deregulated gene network centered around microphthalmia-associated transcription factor, a transcription factor known to play a key role in melanoma development, and define miRNAs and miRNA target genes that offer candidate biomarkers in human melanoma.
Journal ArticleDOI
Interplay of microRNAs, transcription factors and target genes: linking dynamic expression changes to function
Petr V. Nazarov,Susanne E. Reinsbach,Arnaud Muller,Nathalie Nicot,Demetra Philippidou,Laurent Vallar,Stephanie Kreis +6 more
TL;DR: This work investigates simultaneously the transcriptional changes of miRNA and mRNA expression levels over time after activation of the Janus kinase/Signal transducer and activator of transcription (Jak/STAT) pathway by interferon-γ stimulation of melanoma cells and demonstrates the dynamic interplay of miRNAs and upstream regulators with biological functions.
Journal ArticleDOI
Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
Martina Schmitt,Demetra Philippidou,Susanne E. Reinsbach,Christiane Margue,Anke Wienecke-Baldacchino,Dorothee Nashan,Iris Behrmann,Stephanie Kreis +7 more
TL;DR: The findings reveal that the miR-29a/b1 cluster is to be included in the group of IFN- and STAT-regulated genes and may act as effectors of cytokine signalling in melanoma and other cancer cells as well as in the immune system.
Journal ArticleDOI
Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?
Christiane Margue,Susanne E. Reinsbach,Demetra Philippidou,Nicolas Beaume,Casandra Walters,Jochen G. Schneider,Dorothee Nashan,Iris Behrmann,Stephanie Kreis +8 more
TL;DR: There is strong evidence that levels of cell-free miRNAs only change significantly at later stages of melanoma progression, which has serious implications for miRNA biomarker studies in cancer.
Journal ArticleDOI
New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion
Christiane Margue,Demetra Philippidou,Susanne E. Reinsbach,Martina Schmitt,Iris Behrmann,Stephanie Kreis +5 more
TL;DR: It is shown that MITF-correlated miR-211 expression levels are mostly but not always reduced in a panel of 11 melanoma cell lines and in primary and metastatic melanoma compared to normal melanocytes and nevi, respectively, raising serious doubts on the value of miR -211 as a melanoma tumor-suppressing miRNA and/or as a biomarker for melanoma.